Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BNLB, what are you talking about? What exactly is bad about this PR?? Can't be that bad since I you have a big bid in right?
Five cents coming
BNLB.. $0.16.. It looks like they are taking care of the insiders to the benifit of themselves and not the shareholders.. Further they are borrowing money to do so.. The insiders will come out whole while the shareholders will need to hope that the insiders now have enough incentive to push ahead with new product releases that generate revenues and profits..
Past recent PR's have seemed to promise w/o having to show the revenues and profits generated from them.. I could see BNLD churing and slowly falling lower on this news because when present shareholders fighre out what has happened there is little incentive to buy any longer..
It also appears that any hope for an increased rev. and earnings to increase before the reverse has just been taken off the table.. hank
Bond Labs to Simplify Capital Structure
All outstanding preferred stock
redeemed or converted into common stock
OMAHA, Neb., Sep 10, 2013 (BUSINESS WIRE) -- Bond Laboratories, Inc.
(OTCBB:BNLB) ("Bond Labs"),
an international provider of innovative and proprietary nutritional supplements
for health conscious consumers, today announced a recapitalization designed to
simplify its capital structure and significantly reduce its cost of capital.
The transactions described below, will eliminate approximately $3.3 million of
liquidation preference from existing preferred stock and will lower the
Company's total borrowing costs by almost $200,000
per year. Assuming a thirty-five percent corporate tax rate, net borrowing costs
will decline more than threefold from approximately 8.0% to 2.3%.
Critical elements of the transaction include the following:
-- Convert half of the issued and outstanding shares of the
Company's Series C Convertible Preferred Stock and
accrued dividends at $0.25 per share;
-- Redeem half of the issued and outstanding shares of the
Company's Series C Convertible Preferred Stock at par
plus accrued dividends;
-- Redeem issued and outstanding shares of the
Company's 10% Cumulative Perpetual Series B Preferred
Stock at par plus accrued dividends;
-- In connection with the Series C Conversion at $0.25 per share, the Company
has agreed to exchange/cancel 2,500,000 warrants for 625,000 common shares,
thereby reducing the Company's diluted share count by
1,875,000 shares;
-- Complete a reverse stock split at a ratio of 10 for 1, as approved by
shareholders at the recent annual meeting; and
-- Change the corporate name to FitLife Brands, Inc.
Upon the closing of the transactions outlined above, the Company will have
approximately 8.1 million shares of common stock outstanding and 8.6 million
shares of common stock outstanding on a fully-diluted basis and no preferred
shares.
In connection with the recapitalization, the Company secured a $2.6 million term
loan from its existing bank. The new term loan bears interest at a rate of 3.6%
per annum, has no prepayment penalty and amortizes evenly over 5 years. The
Company's existing credit facility shall remain in
place. The recapitalization and name change are expected to close on or before
September 30, subject to final documentation and regulatory approvals.
John Wilson, Chief Executive Officer of Bond Laboratories, Inc., stated,
"We believe the recapitalization will be immediately
accretive to our common shareholders through the simplification of our capital
structure and significantly reduced capital costs. Our name change to FitLife
Brands comes at an exciting time for the company, as the anticipated growth in
our business combined with the recapitalization helps position the company to
deliver record results in 2013."
About Bond Labs Bond Laboratories is a manufacturer of innovative and
proprietary nutritional supplements for health conscious consumers. The Company
produces and markets products through its NDS Nutrition division.
NDS' products number over 60 brands of energy,
sports, and dietary supplements. These products are sold directly through
specialty health and nutrition retailers, and are included among the top-selling
products at GNC(R) franchises. Bond Labs is headquartered in
Omaha, Nebraska. For more information, please visit http://www.bond-labs.com.
Safe Harbor Statements about the Company's future
expectations and all other statements in this press release other than
historical facts, are "forward-looking
statements" within the meaning of Section 27A of the
Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and
as that term is defined in the Private Securities Litigation Reform Act of 1995.
The Company intends that such forward-looking statements be subject to the safe
harbors created thereby. The above information contains information relating to
the Company that is based on the beliefs of the Company and/or its management as
well as assumptions made by and information currently available to the Company
or its management. The company does not undertake any responsibility to update
the forward-looking statements contained in this release.
http://cts.businesswire.com/ct/CT?id=bwnews&sty=20130910006548r1&sid=cmtx6&distro=nx
SOURCE: Bond Laboratories, Inc.
CONTACT:
For Bond Laboratories:
Surety Financial Group, LLC
Bruce Weinstein, 410-833-0078
Copyright Business Wire 2013
-0-
KEYWORD: United States
North America
California
Nebraska
INDUSTRY KEYWORD: Other Sports
Health
Fitness & Nutrition
Manufacturing
Other Manufacturing
Retail
Food/Beverage
Other Science
Specialty
Other Retail
Sports
Science
SUBJECT CODE: Dividend
Earnings
Product/Service
Stock Sale/Buyback
Stock Split
Not really positive. They're spending 80% of their cash, $1.9 million to buy back preferred stock.
And there's still over $1.3 million in preferred C shares out there.
Isn't this positive? Why does it keep going south?
BNLB - .17 Buying back preferred stock.
Form 8-K for BOND LABORATORIES, INC.6-Sep-2013Other Events, Financial Statements and Exhibits
Item 8.01 Other Events. Under the Certificate of Designation of the Relative Rights and Preferences of the 10% Cumulative Perpetual Series B Preferred Stock (the "Certificate of Designation"), the Company may, upon no less than 30, but no more than 60 days written notice, redeem issued and outstanding shares of its 10% Cumulative Perpetual Series B Preferred Stock ("Series B Preferred") for $10,000.00 per share, plus all accrued dividends, less any applicable tax withholding as may be required by law. On August 30, 2013, the Company mailed a notice of redemption (the "Redemption Notice") to all holders of Series B Preferred, notifying each holder of the Company's intention to redeem all issued and outstanding shares of Series B Preferred on September 30, 2013. As of August 30, 2013, there were 103.3 shares of Series B Preferred issued and outstanding. A copy of the Redemption Notice is attached to this Current Report on Form 8-K as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits. See Exhibit Index. Disclaimer. The foregoing description of the Redemption Notice does not purport to be complete, and is qualified in its entirety by reference to the full text of the Redemption Notice, attached hereto as Exhibit 99.1, and is incorporated by reference herein.
BNLB.. $0.155.. Now why didn't I think of that.. But I'm using the Hank Factor to figure this one out.. My gut says that BNLB could splash below $0.14 before it comes up for air with real up-tics.. Stocks usually trade twards the size sides of the quotes.. Until then we should and will see small "Paint " ($0.165) type buys.. hank
BNLB.. $0.15 Bid.. Getting close to a reentry point.. I think as the Nervious nellies get fearfull of a total meltdown I might make sence to buy a few at the bid around $0.15 so it may be reofferd out to help the down spike started earlier last week.. I wonder what the SI boys are up to..?? hank
Loosely using the Fibernaci rules of retracement, this may start to bottom somewhere in this range. (using .625 of the up move, it calculates to .1775.) Anyway, I would think anything below .1775 is a buy. This is where I started to reload.
Still nibbling here and there.
Since you have never made any sense before who cares what you post..?? But I'd be a buyer before/at $0.10.. hank
Back to .10 cents...
Did you participated in the conference call? Any insights?
Hi Catfish, I finally sold all of my BNLB (it finally paid off nicely) but am also looking to buy back in, as I too think it is just 'pausing', though for how long who knows? No cash at the moment though..
You wish!...did you ever buy any shares?
Back to .08 cents ...
Thanks Footloose, but I can't find that in a PR anywhere...where'd you get the info?
2nd Quarter Results
4 PM Eastern start time
Call: 1-605-477-2100
Password: 961421#
Excellent work! I did very well following your lead, however I'm going to disagree about the future. I think BNLB may still have some legs and will be rebuying below .20 and reselling above.
Thanks for selling all of your shares. I am still buying...have a ways to go before I re-buy all of my shares.
Thanks for the support ON my sells if you bought any.. I'm done now and must say since I Ave $0.2366...
I made 121% ON MY POSITION.. GLTA THAT ARE STILL HOLDING.. I WOULD REENTER IF WE WERE TO SEE SUB $0.11 AGAIN.. HANK
I told you before..You guys needed to sell before 10bagger dump
From Wikipedia:
Methylhexanamine, commonly known as 1,3-dimethylamylamine or DMAA, is an organic compound with the formula CH3CH2CH(CH3)CH2CH(CH3)NH2. Methylhexanamine is a simple aliphatic amine initially patented as a nasal decongestant and as a topical treatment for hypertrophied or hyperplastic oral tissues. [2] Methylhexanamine is a vasoconstrictor, and can be administered by inhalation to the nasal mucosa to exert its effect.
Methylhexanamine has also been marketed extensively under many names as a dietary supplement, [3] [4] [5] but its safety has been questioned as a number of adverse events and at least 5 deaths have been associated with methylhexanamine-containing supplements. [6] In April 2013, the U.S. Food and Drug Administration warned supplement makers that it was illegal to market methylhexanamine as a dietary supplement, and warned consumers of potentially serious health risks associated with methylhexanamine-containing products. [6] [7]
tHANKs . Im in at .123, still deciding weather i should let these go. I might hold on til' end of the year with new product sales in hope.
I posted this up on the Bottom Fish Board:
BNLB - They had an outstanding Q. They had non-recurring revenue in 2012, so if that is excluded from the current numbers, they look very good. I am not selling into today's correction, but looking for a place to re-buy some cheap shares.
Revenue for the three and six month periods ended June 30, 2012 included $0.8 million and $1.6 million of non-recurring revenue, respectively, primarily related to the sell through of certain products containing DMAA, an established and widely used ingredient that experienced increased scrutiny from the FDA. Excluding non-recurring revenue related to products containing DMAA that were reformulated during 2012, revenue for the three and six month periods ended June 30, 2013 increased 14.5% and 30.7%, respectively, as compared to the comparable periods in 2012.
BNLB.. It's still up over 100% from the recent lows and I don't think anyone expected the report that was released.. It's been a vertical move that seemed to have outside forces moving it.. Will these continue or will the earnings cause a stall.. Not for sure but with the latest report BNLB will be hard to justify more value ,, especally in the face of a reverse.. BNLB was good to me as were those that gave BNLB a hank Discount on the SI board.. When I'm done I'll also resign as a mod.. hank
Well done 10 bagger. So are you out and dont believe in this stock to increase after you sell your remaining 5%?
BNLB.. $0.18..The earnings laid an egg on the face of the bulls.. Sold another 12% of the org. position since the last post and now on the on the earnings news I am left with only 5% now and that will gone soon.. My gut was right the other day and I should of sold more above $0.25 but was on the road to CT.. I Ave. $0.225 on the last sales which was more than a double on the price paid on the position..
Bond Labs Reports Increase in International GNC Locations
Print
Alert
Bond Laboratories, Inc. (QB) (USOTC:BNLB)
Intraday Stock Chart
Today : Thursday 15 August 2013
Click Here for more Bond Laboratories, Inc. (QB) Charts.
Bond Laboratories, Inc. (OTCBB:BNLB) (“Bond Labs”), an international provider of innovative and proprietary nutritional supplements for health conscious consumers, marketed primarily through its wholly owned operating division, NDS Nutrition Products (“NDS”) (www.ndsnutrition.com), reports that the Company has significantly increased the number of GNC® franchise locations selling its products worldwide over the past six months.
“As of December 31, 2012, we reported that Bond Labs marketed products to over 800 GNC franchise locations nationwide,” stated John Wilson, Bond Labs’ Chief Executive Officer. “I am pleased to announce that during the first six months of 2013 the Company has increased its footprint from 47 to 110 GNC franchise locations internationally and added several new products to our worldwide distribution system. We anticipate doubling that number of international locations by the end of the year while simultaneously increasing the number of products sold in each of those stores.”
“We have made a significant investment in our international growth strategy to date and based on the increase in the number of GNC retail outlets selling our products we are beginning to see results,” continued Mr. Wilson. “As you can imagine, there is a significant lag time between receiving the initial order and making the expenditures necessary to enter into another new market. While the benefits of these investments may not yet be evident in our current revenue numbers, we anticipate that continued international expansion will be a major driver of future growth.”
“International expansion will continue to be a key strategic element of Bond’s long-term growth plan. With GNC recently reporting that they are continuing to expand their global presence, we will strive to further strengthen our relationship so that we can capitalize on future expansion opportunities,” concluded Mr. Wilson.
About Bond Labs
Bond Laboratories is a manufacturer of innovative and proprietary nutritional supplements for health conscious consumers marketed primarily through NDS Nutrition Products (“NDS”), a wholly owned operating division. NDS sells over 50 different dietary supplements to promote sports nutrition, improved performance, weight loss and general health exclusively to GNC® franchises. Bond Labs is headquartered in Omaha, Nebraska. For more information, please visit http://www.bond-labs.com.
Forward-Looking Statement
Statements in this release that are forward looking involve known and unknown risks and uncertainties, which may cause the Company’s actual results in future periods to be materially different from any future performance that may be suggested in this news release. Such factors may include, but are not limited to: the ability to of the Company to continue to grow revenue; the Company’s ability to continue to achieve positive cash flow given the Company's existing and anticipated operating and other costs; and the outcome of the Company’s pending litigation with the U.S. Department of Labor and our former President alleging violations of certain unlawful employment practices in connection with his separation from the Company. Many of these risks and uncertainties are beyond the Company's control. Reference is made to the discussion of risk factors detailed in The Company’s filings with the Securities and Exchange Commission, including its reports on Form 10-K and 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.
Exactly, hold onto this puppy. let it bounce, but don't let go!!
Still expect BNLB to be trading in the $.40-.50 cent range by end of year.
BNLB News...Bond Labs Reports 2nd Quarter and YTD Results
Impressive Domestic and
International Growth Trends Continue
OMAHA, Neb., Aug 14, 2013 (BUSINESS WIRE) -- Bond Laboratories, Inc.
(OTCBB:BNLB) ("Bond Labs"),
a national provider of innovative and proprietary nutritional supplements for
health conscious consumers, today announced significant continued core business
revenue growth and positive net income for the second fiscal quarter and
year-to-date results.
Revenue for the three months ended June 30, 2013 was $5.1 million as compared to
$5.2 million for the comparable period in 2012, a decrease of 2.3%. Revenue for
the six months ended June 30, 2013 was $11.1 million as compared to $10.1
million for the comparable period in 2012, an increase of 9.7%. Revenue for the
three and six month periods ended June 30, 2012 included $0.8 million and $1.6
million of non-recurring revenue, respectively, primarily related to the sell
through of certain products containing DMAA, an established and widely used
ingredient that experienced increased scrutiny from the FDA. Excluding
non-recurring revenue related to products containing DMAA that were reformulated
during 2012, revenue for the three and six month periods ended June 30, 2013
increased 14.5% and 30.7%, respectively, as compared to the comparable periods
in 2012.
Net income for the three and six month periods ended June 30, 2013 was $0.5
million and $1.1 million, respectively, as compared to $0.8 million and $1.5
million, respectively, for the comparable periods in 2012. In addition to
approximately $0.3 million of incremental non-cash issuance costs incurred
during the first half of 2013 over the comparable period in 2012 and the impact
of the non-recurring DMAA activity from 2012, net income for the three and six
months periods ended June 30, 2013 reflect ongoing investment by the Company to
enhance its sales and marketing efforts, which management believes will drive
future domestic and international growth.
During the six month period ended June 30, 2013, Bond Labs generated $1.5
million of cash flow from operations as compared to $0.3 million for the
comparable six-month period ended June 30, 2012.
"With the recent introduction of our new SirenLabs
line, Bond Labs now boasts three high-quality product lines exclusive to the GNC
franchise system: NDS, PMD Sports Nutrition and SirenLabs. Strong brand
awareness, a high-quality reputation and commitment to providing our customers
with innovative and truly differentiated solutions continue to be the primary
drivers behind our success both domestically and
internationally," stated John S. Wilson, Chief
Executive Officer of Bond Labs. "International
expansion remains a critical element of our future growth plan. We now sell a
subset of our total product portfolio in eight of the approximately fifty
countries with GNC locations. Our growth strategy is focused on both expanding
the number of countries in Bond Labs' distribution
footprint as well as increasing the average number of SKUs sold through each
country. It is truly an exciting time at the company and I look forward to
continuing to execute our growth plan to expand the business and create
shareholder value," concluded Mr. Wilson.
About Bond Labs
Bond Laboratories is a manufacturer of innovative and proprietary nutritional
supplements for health conscious consumers. The Company produces and markets
products through its NDS Nutrition division. NDS'
products number over 60 brands of energy, sports, and dietary supplements. These
products are sold directly through specialty health and nutrition retailers, and
are included among the top-selling products at GNC(R) franchises.
Bond Labs is headquartered in Omaha, Nebraska. For more information, please
visit http://www.bond-labs.com.
Safe Harbor
Statements about the Company's future expectations
and all other statements in this press release other than historical facts, are
"forward-looking
statements" within the meaning of Section 27A of the
Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and
as that term is defined in the Private Securities Litigation Reform Act of 1995.
The Company intends that such forward-looking statements be subject to the safe
harbors created thereby. The above information contains information relating to
the Company that is based on the beliefs of the Company and/or its management as
well as assumptions made by and information currently available to the Company
or its management. The company does not undertake any responsibility to update
the forward-looking statements contained in this release.
http://cts.businesswire.com/ct/CT?id=bwnews&sty=20130814005347r1&sid=cmtx6&distro=nx
SOURCE: Bond Laboratories, Inc.
CONTACT:
Surety Financial Group, LLC
Bruce Weinstein, 410-833-0078
Copyright Business Wire 2013
-0-
KEYWORD: United States
North America
Nebraska
INDUSTRY KEYWORD: Health
Fitness & Nutrition
Retail
Specialty
SUBJECT CODE: Earnings
BOND.. $0.27.. Sold a few more today over $0.2599.. Nice gap from most recent sales.. Monentumn seems to be taken hold but BNLB has gone up vertically since $0.10 and took another 3 % of the original position off the table.. Still holding 17% and think a few more tic's around this level must/should be made.. The 1 for 40 seems now to be off the table and might be 1 for 20 if this price holds.. At 1 for 20 the PPS is not as attractive.. hank
just needs volume
BNLB.. $0.28.. New High
Sure glad I didn't hold this one back at $0.12 like the Boys at SI kept posting.. I wonder how nmany are still holding over 200K from the start of the move.. It was I believed given the Hank Factor as a discount to the stock.. Funny if it wasn't an excuse for shoddy DD.. hank
let her rip...still holdin this bad boy...based on the chart
Great to see volume picking up!
Nice to see value validated, although these parabolic moves of late aren't isolated to value stocks. Strange market and I wonder who really is pushing these up in the recent weeks, as I do not believe it is the little investors. Perhaps sensitive computer programs that react strongly when the overall market moves at a certain pace..or market makers working together..dunno.. I've taken profits, but still have 40% in BNLB because it is still undervalued and now we have momentum working for us as the 'discovery' of this gem continues..
BNLB.. $0.25.. New high..
BNLB.. $0.22.. The march continues.. Are we almost there yet.. I've sold another 6% over $0.1999..
Have 20% still left of the starting position.... Good luck to the new longs.. As this is an investment position those shares are now locked away for LT capitol gains.. hank
This is one of those slow gainers. BNLB has good stats and speaks for itself to long holders. Flippers don't see a quick return so volume is low IMO.
Does it need a little pump to bring some volume?
Followers
|
25
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
766
|
Created
|
10/09/08
|
Type
|
Free
|
Moderators |
Bond Laboratories™ is a national provider of Innovative Proprietary Nutritional Supplements for health conscious consumers. The Company produces and markets its products through its operating division NDS Nutrition.
NDS manufactures and distributes a full line of nutritional supplements to support healthy living through a variety of retail channels including GNC franchise locations located throughout the United States.
O/S Shares Outstanding 74,171,996 a/o Nov 04, 2011
A/S 150,000,000 shares authorized
SEC FILINGS: http://sec.gov/cgi-bin/browse-edgar?company=Bond+Laboratories&CIK=&filenum=&State=&SIC=&owner=include&action=getcompany
NDS' experience and innovation toward producing new and exciting weight loss products has made us a leading pioneer within the industry since 2002. Whether it is a full, multiple product weight loss kit, a single calorie burning thermogenic or a daily body toning supplement for weight loss and maintenance, NDS Nutrition has a long and proud history of providing high quality weight loss solutions that work. NDS' weight loss products provide a strong impact that resonates with customers. Reach, achieve and surpass your health, fitness and training goals with NDS' high quality weight loss solutions.
www.ndsnutrition.com
NDS' PMD® sports nutrition line is an exclusive and high quality sports nutrition line of products that not only meet and exceed customer expectations, but also soar past the threshold of what's expected. When in need of professional caliber supplements, look no further than PMD, your source for Professional Muscular Development. These highly innovative and fully loaded supplements are only equipped with the purest and highest quality ingredients necessary to achieve extraordinary results. Whether you are in the gym 7 days a week or just a novice enthusiast, everyone can use a little bit of help building some good lean muscle or achieving a particular desired look. After all, isn't a muscular or well-defined body something everyone would like to achieve? When it comes to meeting those fitness and training goals, the only true solution is PMD.
Bond Labs Achieves Turnaround; Generating Record 2011 Results |
|
Bond Laboratories (OTCBB:BNLB) |
http://store.ndsnutrition.com/
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Bond Laboratories, Inc. website: http://www.fusionenergyboost.com/ And: http://www.bond-labs.com/
Bond Laboratories is a company of Innovative Proprietary Sports Nutrition and Dietary Supplement Products for the next generation. Bond Labs is based in Omaha, Nebraska.
For inquiries regarding investor relations, please contact:
Bruce M. Weinstein, CPA
642 Main Street
Reisterstown, MD 21136
410.833.0078 ext. 205
410.833.0552 (fax)
bweinstein@suretyfingroup.com
O/S Shares Outstanding 74,171,996 a/o Nov 04, 2011
A/S 150,000,000 shares authorized
READ THE LATEST 10-Q and other info FOR YOURSELF TO CHECK MY POSTED FACTS! DON'T RELY ON ME!!!----
http://www.bond-labs.com/brands.html
BNLB - Weekly Candlesticks
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |